EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Azenta's enterprise value is $983.4 Mil.
Azenta's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $31.4 Mil. Therefore, Azenta's EV-to-EBITDA for today is 31.33.
The historical rank and industry rank for Azenta's EV-to-EBITDA or its related term are showing as below:
AZTA'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -1928.95 Med: 44.6 Max: 1125.91
Current: 31.33
During the past 13 years, the highest EV-to-EBITDA of Azenta was 1125.91. The lowest was -1928.95. And the median was 44.60.
AZTA's EV-to-EBITDA is ranked worse than 77.28% of 493
companies
in the Medical Devices & Instruments industry
Industry Median: 15.45
vs AZTA: 31.33
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2025-05-22), Azenta's stock price is $27.48.
Azenta's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $-1.399. Therefore, Azenta's PE Ratio (TTM) for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Azenta EV-to-EBITDA Historical Data
The historical data trend for Azenta's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Azenta's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Azenta's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Azenta's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Azenta's EV-to-EBITDA falls into.
Azenta's current Enterprise Value is $983.4 Mil.
Azenta's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $31.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Azenta (NAS:AZTA) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Azenta's share price for today is $27.48.
Azenta's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.399.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thank you for viewing the detailed overview of Azenta's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AZTA has been successfully added to your 